Medix Inc. (TYO:331A)
Japan · Delayed Price · Currency is JPY 503.00
-1.00 (-0.20%)
Aug 5, 2026, 9:00 AM JST
Medix Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 4,064 | 3,771 | 2,780 | 2,363 | 1,778 |
Cash & Short-Term Investments | 4,064 | 3,771 | 2,780 | 2,363 | 1,778 |
Cash Growth | 7.77% | 35.65% | 17.65% | 32.89% | 27.64% |
Receivables | 2,548 | 2,226 | 2,292 | 2,242 | 2,227 |
Inventory | - | - | - | - | 91.43 |
Prepaid Expenses | - | 103 | 98 | 97 | - |
Other Current Assets | 134 | 2 | 5 | 13 | 58.9 |
Total Current Assets | 6,746 | 6,102 | 5,175 | 4,715 | 4,155 |
Property, Plant & Equipment | 122 | 114 | 132 | 111 | 111.03 |
Long-Term Investments | 326 | 177 | 446 | 430 | - |
Goodwill | 306 | - | - | - | - |
Other Intangible Assets | 27 | 22 | 34 | 40 | 41.18 |
Long-Term Deferred Tax Assets | 204 | 235 | 94 | 112 | - |
Other Long-Term Assets | 1 | 2 | 1 | 1 | 830.03 |
Total Assets | 7,732 | 6,669 | 5,903 | 5,431 | 5,137 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | - | - | - | 2,071 |
Accrued Expenses | 150 | 176 | 210 | 270 | - |
Short-Term Debt | - | - | - | - | 299.5 |
Current Portion of Long-Term Debt | 183 | 95 | 229 | 244 | - |
Current Portion of Leases | 2 | 2 | 2 | - | - |
Current Income Taxes Payable | 2,472 | 2,393 | 2,514 | 2,210 | - |
Other Current Liabilities | 270 | 166 | 170 | 238 | 867.02 |
Total Current Liabilities | 3,077 | 2,832 | 3,125 | 2,962 | 3,237 |
Long-Term Debt | 633 | 16 | 111 | 252 | 169 |
Long-Term Leases | 5 | 8 | 11 | - | - |
Pension & Post-Retirement Benefits | 452 | 532 | 488 | 476 | - |
Other Long-Term Liabilities | 3 | 13 | 11 | 12 | 375.18 |
Total Liabilities | 4,170 | 3,401 | 3,746 | 3,702 | 3,782 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 259 | 259 | 75 | 75 | 1,356 |
Additional Paid-In Capital | 230 | 262 | 78 | 78 | - |
Retained Earnings | 3,086 | 2,762 | 2,018 | 1,575 | - |
Treasury Stock | -204 | -16 | -16 | - | - |
Comprehensive Income & Other | 65 | 1 | 2 | 1 | - |
Total Common Equity | 3,436 | 3,268 | 2,157 | 1,729 | 1,356 |
Minority Interest | 126 | - | - | - | - |
Shareholders' Equity | 3,562 | 3,268 | 2,157 | 1,729 | 1,356 |
Total Liabilities & Equity | 7,732 | 6,669 | 5,903 | 5,431 | 5,137 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 823 | 121 | 353 | 496 | 468.5 |
Net Cash (Debt) | 3,241 | 3,650 | 2,427 | 1,867 | 1,310 |
Net Cash Growth | -11.21% | 50.39% | 30.00% | 42.56% | 242.49% |
Net Cash Per Share | 410.12 | 466.91 | 321.73 | 246.31 | - |
Filing Date Shares Outstanding | 7.67 | 7.6 | 7.54 | 7.58 | - |
Total Common Shares Outstanding | 7.67 | 7.6 | 7.54 | 7.58 | - |
Working Capital | 3,669 | 3,270 | 2,050 | 1,753 | - |
Book Value Per Share | 448.13 | 430.24 | 285.94 | 228.10 | - |
Tangible Book Value | 3,103 | 3,246 | 2,123 | 1,689 | - |
Tangible Book Value Per Share | 404.70 | 427.34 | 281.43 | 222.82 | - |